Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
INDIVIOR INC. et al v. DR. REDDY'S LABORATORIES, INC. et al
Case Number:
2:18-cv-05288
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
June 24, 2022
Dr. Reddy's Gets $72M In Generic Suboxone Settlement
Indivior, Aquestive and Dr. Reddy's Laboratories have ended their yearslong litigation battle over generic versions of the opioid addiction treatment Suboxone, with the Indian drugmaker on Friday saying it will receive $72 million by April 2024.
-
May 05, 2020
Indivior Can Split IP, Antitrust Claims In Suboxone Fight
A New Jersey federal judge agreed Tuesday to split patent infringement and antitrust allegations in the legal battle between Indivior Inc. and generic pharmaceutical companies over opioid addiction treatment Suboxone, ruling that jurors might be confused if all the claims were tried together.
-
July 13, 2018
Indivior Wins Bid To Block Sales Of Suboxone Generic
Determining that drugmaker Indivior will likely be able to show its suit claiming infringement by Dr. Reddy's of a so-called child patent covering its Suboxone Film will not be precluded by a suit in which Dr. Reddy's was cleared of infringement of the parent patent, a New Jersey federal judge on Friday granted Indivior a preliminary injunction blocking sales.